Suchergebnisse - "Troiani, Teresa"

PubPharm (245)

1

PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer

enthalten in: Biomedicines | 2024

von De Rosa, C. | Iommelli, F. | De Rosa, V. | +19

2

Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer : A Nonrandomized Controlled Trial

enthalten in: JAMA network open | 2024

von Ciardiello, D. | Martinelli, E. | Troiani, T. | +19

3

All for one : Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of "difficult to treat" non melanoma skin cancer

enthalten in: Clinical and translational radiation oncology | 2024

von Gagliardi, F. | Russo, A. | Scharf, C. | +7

4

Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins : a Delphi consensus

enthalten in: The British journal of dermatology | 2024

von Moscarella, E. | Di Brizzi, E. | Alpi, P. | +22

5

The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis : A Narrative Review

enthalten in: Cancers | 2024

von Gravina, A. | Pellegrino, R. | Esposito, A. | +6

6

Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment : A Narrative Literature Review

enthalten in: Healthcare (Basel, Switzerland) | 2024

von Basilicata, M. | Terrano, V. | D'Aurelio, A. | +4

7

The Role of Sentinel Node Biopsy in the Era of Adjuvant Therapy for Melanoma

enthalten in: Dermatology practical & conceptual | 2024

von Brancaccio, G. | Briatico, G. | Scharf, C. | +12

8

Targeting EphA2 and DDR signaling can overcome the BRAF and MEK inhibitors acquired resistance in melanoma cell lines

enthalten in: ResearchSquare.com | 2023

von Belli, V. | Napolitano, S. | De Falco, V. | +13

9

Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer : Overall survival and subgroup analysis of the randomized phase II VELO trial

enthalten in: International journal of cancer | 2023

von Napolitano, S. | Ciardiello, D. | De Falco, V. | +19

10

Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer

enthalten in: British journal of cancer | 2023

von Belli, S. | Pesapane, A. | Servetto, A. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]